Xeris Biopharma Holdings (XERS) Exchange Rate Effect (2020 - 2022)
Xeris Biopharma Holdings' (XERS) quarterly Exchange Rate Effect came in at $1000.0 in Q3 2022, up 150.0% YoY from $400.0 in Q3 2021, and up 200.0% on a QoQ basis from -$1000.0 in Q1 2022.
Xeris Biopharma Holdings (XERS) Exchange Rate Effect (2020 - 2022) Analysis & Trends
Xeris Biopharma Holdings (XERS) has 3 years of Exchange Rate Effect data on file, last reported at $1000.0 in Q3 2022.
- Quarterly Exchange Rate Effect rose 150.0% year-over-year to $1000.0 in Q3 2022, while the trailing twelve-month figure through Jun 2023 was $1000.0 (up 120.0% YoY) and the FY2021 annual result came in at -$3000.0, up 86.36% from the prior year.
- Exchange Rate Effect rose to $1000.0 in Q3 2022, from -$1000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $6000.0 in Q4 2020 to a low of -$2000.0 in Q3 2021.
- A 3-year average of $500.0 and a median of $0.0 in 2021 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2021 — Exchange Rate Effect tumbled 133.33% — and 2022, when it soared 150.0%.
- Tracing XERS's Exchange Rate Effect over 3 years: stood at $6000.0 in 2020, then sank by 133.33% to -$2000.0 in 2021, then soared by 150.0% to $1000.0 in 2022.
- The last three Exchange Rate Effect figures came in at $1000.0 (Q3 2022), -$1000.0 (Q1 2022), and -$2000.0 (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -5.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | -7.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 39.87 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -3.30 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 9.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Xeris Biopharma Holdings | 1.51 Bn | 1.39 Bn | 79.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 1,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Mar 31, 2022 | -1,000.00 |
| Mar 31, 2022 | -1,000.00 |
| Dec 31, 2021 | -2,000.00 |
| Dec 31, 2021 | -2,000.00 |
| Sep 30, 2021 | -2,000.00 |
| Sep 30, 2021 | -2,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Dec 31, 2020 | 6,000.00 |
| Dec 31, 2020 | 6,000.00 |